Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation

NCT ID: NCT07012616

Last Updated: 2026-01-29

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-06-10
• Study Completion Date: 2026-01-15

Brief Summary

This study aims to evaluate the efficacy of supraclavicular brachial plexus block as an opioid-sparing technique in pediatric patients undergoing arteriovenous fistula creation.

Detailed Description

The global incidence of end-stage renal failure (ESRF) is increasing. The preferred procedure for patients with ESRF undergoing maintenance Haemodialysis (HD) is the placement of an arteriovenous fistula (AVF).

In patients with ESRF, brachial plexus block (BPB) is frequently employed to administer anesthesia for the establishment or modification of AVF. This technique offers pain relief, sympathetic blockade, ideal surgical conditions, and a sufficient duration of postoperative block, preventing arterial spasms and graft thrombosis

Conditions

Supraclavicular Brachial Plexus Block; Opioid Sparing; Pediatric; Arteriovenous Fistula

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Supraclavicular brachial plexus block group

Patients will receive an ultrasound-guided supraclavicular brachial plexus block.

Group Type: EXPERIMENTAL

Supraclavicular brachial plexus block

Intervention Type: OTHER

Patients will receive an ultrasound-guided supraclavicular brachial plexus block.

Control group

Patients will not receive supraclavicular brachial plexus block as a control group.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Supraclavicular brachial plexus block

Patients will receive an ultrasound-guided supraclavicular brachial plexus block.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age from 6 to 18 years.
• Both sexes.
• American Society of Anesthesiology (ASA) physical status I- III.
• Undergoing arteriovenous fistula creation under general anesthesia.

Exclusion Criteria

• Allergy to local anesthetics.
• Infection at the site of block.
• Local infection.
• Coagulation disorder.
• Previously failed or revision of blocked arteriovenous fistula.

• Minimum Eligible Age: 6 Years
• Maximum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Tanta University

OTHER

Sponsor Role: lead

Responsible Party

Mohammed Said ElSharkawy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Tanta University

Tanta, El-Gharbia, Egypt

Countries

Egypt

Other Identifiers

36264PR1208/5/25

Identifier Type: -

Identifier Source: org_study_id